Table 2. Basic clinical features of the 75 MYH9-RD patients described in this study.

Gender - n° (%)
Female	43	(57%)
Male	32
Age - years
Mean	31.3
range	1–87
Position of MYH9 mutation - n° (%)
Motor domain	17	(23%)
Tail domain		58
Proteinuric nephropathy - n° (%)
Yes	20	(27%)
No	55
Sensorineural hearing loss - n° (%)
Yes	40	(53%)
No	35
Cataract - n° (%)
Yes	10	(13%)
No	65

Proteinuric nephropathy, sensorineural hearing loss, and cataracts were evaluated as previously reported (Pecci et al, Hum Mutat 2008, reference 2).